Diabetic Nephropathies Clinical Trials

110 clinical trials for Diabetic Nephropathies across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of WAL0921 in Patients With Glomerular Kidney Diseases — RECRUITING · PHASE2
• Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis — RECRUITING
• Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease — RECRUITING · PHASE3
• Transformative Research in Diabetic Nephropathy 2.0 — RECRUITING
• Transformative Research in Diabetic Nephropathy — RECRUITING
• Formoterol in Diabetes — RECRUITING · PHASE2
• Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors — RECRUITING
• ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases — RECRUITING · PHASE4
• Effect of Acute Hypoxia on Renal Hemodynamic in Healthy Volunteers, Patients With Diabetes and Patients With Diabetes and Kidney Disease — RECRUITING · NA
• Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study — RECRUITING
• Uric Acid Lowering Trial in Youth Onset T2D — COMPLETED · PHASE2
• Diabetic Nephropathy, Glycemic Control and Pseudophakic Macular Edema After Cataract Surgery — ACTIVE_NOT_RECRUITING
• Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study) — ACTIVE_NOT_RECRUITING
• Nutritional Outcomes of Lotus Seed (Nelumbo Nucifera) on Diabetic Sensorimotor Polyneuropathy — COMPLETED · NA
• Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease — COMPLETED · PHASE2
• Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria — COMPLETED · PHASE2
• The Hong Kong Diabetes Biobank — ACTIVE_NOT_RECRUITING
• Irisin Hormone as a Novel Diagnostic Marker for Detection and Progression of Diabetic Nephrophathy Patients — NOT_YET_RECRUITING
• A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes — ACTIVE_NOT_RECRUITING · PHASE2
• Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease — SUSPENDED · PHASE2
• The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. — ACTIVE_NOT_RECRUITING · PHASE3
• Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes — COMPLETED · PHASE1
• Basic Needs Navigation Intervention to Address Multidimensional Adversity in African Americans With Diabetic Kidney Disease — COMPLETED · NA
• Effect of High-intensity Laser Exercise Versus Moderate-intensity Aerobic Exercise on Diabetic Polyneuropathy Patients — COMPLETED · NA
• Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease — TERMINATED · PHASE1
• Stem Cell Therapy for Chronic Kidney Disease — COMPLETED · PHASE1
• MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus — ACTIVE_NOT_RECRUITING
• Cholesterol Metabolism in Plasma and Interstitial Fluid Among Subjects Undergoing Hemodialysis. — SUSPENDED
• Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy — COMPLETED · PHASE4
• Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia — NOT_YET_RECRUITING · PHASE2
• MRI Biomarkers in Diabetic Kidney Disease — COMPLETED
• Effect of High Intensity Interval Versus Moderate Intensity Continuous Training on Microalbuminurea — COMPLETED · NA
• This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated — COMPLETED · PHASE1
• Serum Uromodulin and DN Systematic Review and Meta Analysis — COMPLETED
• Assessment of the Association Between Visceral Obesity and the Progression of Diabetic Nephropathy — NOT_YET_RECRUITING
• A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease — COMPLETED · PHASE2
• Clinical Outcome of Vinpocetine in Diabetic Nephropathy — OTHER · PHASE2
• Efficacy and Safety of Telmisartan Compared With Losartan — OTHER · PHASE4
• A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) — COMPLETED · PHASE4
• Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease — COMPLETED · PHASE4
• Henagliflozin Delays the Progress of Diabetic Nephropathy Via Regulates Gut-Renal Axis — OTHER · NA
• Efficacy and Safety of Finerenone in Heart Failure With Reduced Ejection Fraction — OTHER
• The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD — OTHER
• Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases — OTHER
• To Explore the Anti-oxidative Effects and Inflammation Effects of Soy Protein to Renal Function of End Stage Diabetes Nephropathy Patients — COMPLETED · NA
• Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance — COMPLETED
• A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease — TERMINATED · PHASE2
• Niclosamide Role in Diabetic Nephropathy — COMPLETED · PHASE3
• Assessment of the Accuracy of Continuous Glucose Sensors in People With Diabetes Undergoing Haemodialysis — COMPLETED · NA
• Huangqi Guizhi Wuwu Decoction in CKD Stage 2-4 Diabetic Nephropathy — OTHER · NA

Refine this search